Aging and age-related diseases - From endocrine therapy to target therapy

作者：Bao, Qi; Pan, Jie; Qi, Hangfei; Wang, Lu; Qian, Huan; Jiang, Fangzhen; Shao, Zheren; Xu, Fengzhi; Tao, Zhiping; Ma, Qi; Nelson, Peter; Hu, Xueqing^*

来源：Molecular and Cellular Endocrinology, 2014, 394(1-2): 115-118.

DOI：10.1016/j.mce.2014.07.005

• Aging
• Age-related diseases
• Endocrine
• Gene

Aging represents an important health issue not only for the individual, but also for society in general. Burdens associated with aging are expanding as longevity increases. This has led to an enhanced focus on issues related to aging and age-related diseases. Until recently, anti-aging endocrine-therapy has been largely limited to hormone-replacement therapy (HRT) that is associated with multiple side effects, including an increased risk of cancer. This has greatly limited the application of HRT in anti-aging therapy. Recently, the focus of anti-aging research has expanded from endocrine signaling pathways to effects on regulatory gene networks. In this regard, the GHRH-GH-IGF-1/Insulin, TOR-S6K1,NAD(+)-Sirtuin, P53, Klotho and APOE pathways have been linked to processes associated with age-related diseases, including cancer, cardiovascular disease, diabetes, osteoporosis, and neurodegenerative diseases, all of which directly influence health in aging, and represent key targets in anti-aging therapy.

• 出版日期2014-8-25
• 单位浙江大学